Showing results (191-200 of 1,343) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|April 14, 2010
Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugsD Wang, Y Guo, S A Wrighton, et al.
The Pharmacogenomics Journal|September 14, 2006
Use of pairwise marker combination and recursive partitioning in a pharmacogenetic genome-wide scanL L Warren, A R Hughes, E H Lai, et al.
The Pharmacogenomics Journal|September 27, 2006
IMPDH1 promoter mutations in a patient exhibiting azathioprine resistanceR L Roberts, R B Gearry, M L Barclay, et al.
The Pharmacogenomics Journal|June 15, 2007
ABCB1 genetic polymorphism influences the pharmacology of the new pyrrolobenzodiazepine derivative SJG-136R E Aird, M Thomson, J S Macpherson, et al.
The Pharmacogenomics Journal|August 5, 2009
Application of principal component analysis to pharmacogenomic studies in CanadaH Visscher, C J D Ross, M-P Dubé, et al.
The Pharmacogenomics Journal|June 24, 2009
Influence of ethnicity on pharmacogenetic variation in the Ghanaian populationJ L Yen-Revollo, D J Van Booven, E J Peters, et al.
The Pharmacogenomics Journal|June 24, 2009
Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivorsH Landmark-Høyvik, K V Reinertsen, J H Loge, et al.
The Pharmacogenomics Journal|July 29, 2009
Association of a functional polymorphism in the adrenomedullin gene (ADM) with response to paroxetineD M Glubb, P C McHugh, X Deng, et al.
The Pharmacogenomics Journal|September 2, 2009
Association of polymorphisms in the carbonic anhydrase 6 gene with salivary buffer capacity, dental plaque pH, and caries index in children aged 7-9 yearsR C R Peres, G Camargo, L S Mofatto, et al.
The Pharmacogenomics Journal|August 26, 2009
eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertensionV C Sandrim, A C T Palei, M R Luizon, et al.
Pageof 135